soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) antibody and antigen (Recombinant protein)
Diagnostic soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) antibodies (anti-soluble fragment of triggering receptor expressed on myeloid cells 2, anti-sTREM2) and antigens (recombinant soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) protein) for Neurodegenerative diseases sTREM2 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-sTREM2-Ag01 | Recombinant human TREM2/sTREM2 Protein | 3090 |
GMP-h-sTREM2-Ab01 | Anti-human TREM2/sTREM2 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-sTREM2-Ab02 | Anti-human TREM2/sTREM2 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-sTREM2-Ab03 | Anti-human TREM2/sTREM2 human monoclonal antibody (mAb) | 1953 |
GMP-h-sTREM2-Ab04 | Anti-human TREM2/sTREM2 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-sTREM2-Ag01 |
Product Name | Recombinant human TREM2/sTREM2 Protein |
Target/Biomarker | soluble fragment of triggering receptor expressed on myeloid cells 2(sTREM2) |
Alias of Target/Biomarker | PLOSL2, TREM-2, Trem2a, Trem2b, Trem2c |
Expression platform | synthesized |
Isotypes | NA |
Bioactivity validation | soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in sTREM2 level test of Neurodegenerative diseases (Alzheimer Disease (AD)) and related syndrome evaluation. |
Products description | Recombinant human TREM2/sTREM2 Protein was expressed in synthesized expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control,ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-sTREM2-Ab01, GMP-h-sTREM2-Ab02 |
Product Name | Anti-human TREM2/sTREM2 mouse monoclonal antibody (mAb) |
Target/Biomarker | soluble fragment of triggering receptor expressed on myeloid cells 2(sTREM2) |
Alias of Target/Biomarker | PLOSL2, TREM-2, Trem2a, Trem2b, Trem2c |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) antibodies in sTREM2 level test of Neurodegenerative diseases (Alzheimer Disease (AD)) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human TREM2/sTREM2 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-sTREM2-Ab03, GMP-h-sTREM2-Ab04 |
Product Name | Anti-human TREM2/sTREM2 human monoclonal antibody (mAb) |
Target/Biomarker | soluble fragment of triggering receptor expressed on myeloid cells 2(sTREM2) |
Alias of Target/Biomarker | PLOSL2, TREM-2, Trem2a, Trem2b, Trem2c |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Human soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) antibodies in sTREM2 level test of Neurodegenerative diseases (Alzheimer Disease (AD)) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human TREM2/sTREM2 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
TREM2 is a microglial transmembrane protein that is proteolytically processed to release a soluble fragment (sTREM2). Meta-analysis of available data finds sTREM2 levels are somewhat higher in people with AD than in controls (effect size = 1.314, p <0.0001).
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.